US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist
  • 1.170
  • +0.030+2.63%
Close Aug 27 16:00 ET
34.92MMarket Cap-536P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.16%-14.38M
-51.72%-17.59M
-59.25%-53.29M
-123.46%-17.07M
-24.38%-11.8M
-33.65%-12.82M
-72.00%-11.6M
-63.36%-33.46M
15.07%-7.64M
-102.24%-9.49M
Net income from continuing operations
8.66%-14.44M
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
-63.32%-11.34M
Other non cash items
----
----
-31.17%53K
--0
-35.00%13K
10.53%21K
5.56%19K
--77K
--20K
--20K
Change In working capital
-190.05%-1.33M
-209.40%-2.27M
56.91%5.83M
-135.50%-1.1M
297.88%3.38M
322.78%1.48M
366.29%2.08M
11,518.75%3.72M
262.13%3.09M
-54.82%849K
-Change in prepaid assets
31.93%-795K
49.46%1.11M
38.86%-1.03M
-287.05%-621K
-96.69%21K
43.79%-1.17M
231.10%742K
-20.98%-1.68M
131.92%332K
4.11%634K
-Change in payables and accrued expense
-129.03%-774K
-324.33%-3.03M
14.14%6.25M
-104.72%-140K
1,599.37%2.37M
152.46%2.67M
-16.02%1.35M
489.13%5.47M
343.23%2.97M
-115.71%-158K
-Change in other current liabilities
1,238.10%239K
-1,721.05%-346K
896.10%613K
-1,435.00%-307K
4,900.00%960K
-10.53%-21K
-5.56%-19K
---77K
---20K
---20K
-Change in other working capital
----
----
----
----
----
----
----
----
----
48.86%393K
Cash from discontinued investing activities
Operating cash flow
-12.16%-14.38M
-51.72%-17.59M
-59.25%-53.29M
-123.46%-17.07M
-24.38%-11.8M
-33.65%-12.82M
-72.00%-11.6M
-63.36%-33.46M
15.07%-7.64M
-102.24%-9.49M
Investing cash flow
Cash flow from continuing investing activities
108.96%16.46M
141.48%26.29M
-98.79%-43.28M
-93.06%420K
-2,595.81%-62.46M
119.95%7.88M
-22.11%10.89M
56.48%-21.77M
-3.06%6.06M
66.83%-2.32M
Net investment purchase and sale
108.96%16.46M
141.48%26.29M
-98.79%-43.28M
-93.06%420K
-2,595.81%-62.46M
119.95%7.88M
-22.11%10.89M
56.48%-21.77M
-3.06%6.06M
66.83%-2.32M
Cash from discontinued investing activities
Investing cash flow
108.96%16.46M
141.48%26.29M
-98.79%-43.28M
-93.06%420K
-2,595.81%-62.46M
119.95%7.88M
-22.11%10.89M
56.48%-21.77M
-3.06%6.06M
66.83%-2.32M
Financing cash flow
Cash flow from continuing financing activities
0
75.38%349K
20.81%84.99M
-321K
660,760.00%66.07M
165.39%19.05M
-99.69%199K
-10.42%70.36M
0
95.83%-10K
Net common stock issuance
----
----
20.13%84.53M
---321K
658,100.00%65.8M
----
----
--70.37M
--0
---10K
Proceeds from stock option exercised by employees
--0
75.38%349K
4,327.27%465K
--0
--266K
--0
1,909.09%199K
-200.00%-11K
--0
--0
Cash from discontinued financing activities
Financing cash flow
--0
75.38%349K
20.81%84.99M
---321K
660,760.00%66.07M
165.39%19.05M
-99.69%199K
-10.42%70.36M
--0
95.83%-10K
Net cash flow
Beginning cash position
-7.55%24.69M
-42.51%15.65M
125.01%27.22M
13.24%32.62M
0.48%40.81M
-67.63%26.71M
125.01%27.22M
197.22%12.1M
82.14%28.8M
46.47%40.62M
Current changes in cash
-85.28%2.08M
1,873.73%9.05M
-176.52%-11.57M
-971.95%-16.97M
30.62%-8.2M
133.66%14.1M
-100.72%-510K
88.39%15.12M
57.40%-1.58M
0.86%-11.81M
End cash Position
-34.41%26.77M
-7.55%24.69M
-42.51%15.65M
-42.51%15.65M
13.24%32.62M
0.48%40.81M
-67.63%26.71M
125.01%27.22M
125.01%27.22M
82.14%28.8M
Free cash flow
-12.16%-14.38M
-51.72%-17.59M
-59.25%-53.29M
-123.46%-17.07M
-24.38%-11.8M
-33.65%-12.82M
-72.00%-11.6M
-63.36%-33.46M
15.07%-7.64M
-102.24%-9.49M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.16%-14.38M-51.72%-17.59M-59.25%-53.29M-123.46%-17.07M-24.38%-11.8M-33.65%-12.82M-72.00%-11.6M-63.36%-33.46M15.07%-7.64M-102.24%-9.49M
Net income from continuing operations 8.66%-14.44M-8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M-63.32%-11.34M
Other non cash items ---------31.17%53K--0-35.00%13K10.53%21K5.56%19K--77K--20K--20K
Change In working capital -190.05%-1.33M-209.40%-2.27M56.91%5.83M-135.50%-1.1M297.88%3.38M322.78%1.48M366.29%2.08M11,518.75%3.72M262.13%3.09M-54.82%849K
-Change in prepaid assets 31.93%-795K49.46%1.11M38.86%-1.03M-287.05%-621K-96.69%21K43.79%-1.17M231.10%742K-20.98%-1.68M131.92%332K4.11%634K
-Change in payables and accrued expense -129.03%-774K-324.33%-3.03M14.14%6.25M-104.72%-140K1,599.37%2.37M152.46%2.67M-16.02%1.35M489.13%5.47M343.23%2.97M-115.71%-158K
-Change in other current liabilities 1,238.10%239K-1,721.05%-346K896.10%613K-1,435.00%-307K4,900.00%960K-10.53%-21K-5.56%-19K---77K---20K---20K
-Change in other working capital ------------------------------------48.86%393K
Cash from discontinued investing activities
Operating cash flow -12.16%-14.38M-51.72%-17.59M-59.25%-53.29M-123.46%-17.07M-24.38%-11.8M-33.65%-12.82M-72.00%-11.6M-63.36%-33.46M15.07%-7.64M-102.24%-9.49M
Investing cash flow
Cash flow from continuing investing activities 108.96%16.46M141.48%26.29M-98.79%-43.28M-93.06%420K-2,595.81%-62.46M119.95%7.88M-22.11%10.89M56.48%-21.77M-3.06%6.06M66.83%-2.32M
Net investment purchase and sale 108.96%16.46M141.48%26.29M-98.79%-43.28M-93.06%420K-2,595.81%-62.46M119.95%7.88M-22.11%10.89M56.48%-21.77M-3.06%6.06M66.83%-2.32M
Cash from discontinued investing activities
Investing cash flow 108.96%16.46M141.48%26.29M-98.79%-43.28M-93.06%420K-2,595.81%-62.46M119.95%7.88M-22.11%10.89M56.48%-21.77M-3.06%6.06M66.83%-2.32M
Financing cash flow
Cash flow from continuing financing activities 075.38%349K20.81%84.99M-321K660,760.00%66.07M165.39%19.05M-99.69%199K-10.42%70.36M095.83%-10K
Net common stock issuance --------20.13%84.53M---321K658,100.00%65.8M----------70.37M--0---10K
Proceeds from stock option exercised by employees --075.38%349K4,327.27%465K--0--266K--01,909.09%199K-200.00%-11K--0--0
Cash from discontinued financing activities
Financing cash flow --075.38%349K20.81%84.99M---321K660,760.00%66.07M165.39%19.05M-99.69%199K-10.42%70.36M--095.83%-10K
Net cash flow
Beginning cash position -7.55%24.69M-42.51%15.65M125.01%27.22M13.24%32.62M0.48%40.81M-67.63%26.71M125.01%27.22M197.22%12.1M82.14%28.8M46.47%40.62M
Current changes in cash -85.28%2.08M1,873.73%9.05M-176.52%-11.57M-971.95%-16.97M30.62%-8.2M133.66%14.1M-100.72%-510K88.39%15.12M57.40%-1.58M0.86%-11.81M
End cash Position -34.41%26.77M-7.55%24.69M-42.51%15.65M-42.51%15.65M13.24%32.62M0.48%40.81M-67.63%26.71M125.01%27.22M125.01%27.22M82.14%28.8M
Free cash flow -12.16%-14.38M-51.72%-17.59M-59.25%-53.29M-123.46%-17.07M-24.38%-11.8M-33.65%-12.82M-72.00%-11.6M-63.36%-33.46M15.07%-7.64M-102.24%-9.49M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg